Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Aug;80(11):1708–1717. doi: 10.1038/sj.bjc.6690587

Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line

R Hasina 1,2, K Matsumoto 1, N Matsumoto-Taniura 1, I Kato 2, M Sakuda 2, T Nakamura 1
PMCID: PMC2363114  PMID: 10468286

Abstract

Invasive potentials of malignant cancer cells are regulated by cell motility factors. To examine the regulation of motility and invasiveness in oral squamous carcinoma, we investigated autocrine- and/or paracrine-acting cell motility factors, using a newly established human cell line (IF cells) from oral squamous cell carcinoma, which has highly invasive and metastatic characteristics. Conditioned medium derived from IF cells stimulated cell scattering and migration of GB-d1 gallbladder carcinoma cells, indicating that IF cells secreted cell motility factors. Using antibodies, IF-derived cell motility factors proved to be transforming growth factor (TGF)-α and TGF-β1. Antibodies against TGF-α and TGF-β1 inhibited autonomous migration of the IF cells. On the other hand, in vitro invasion of IF cells was strongly enhanced by hepatocyte growth factor (HGF) but only slightly by TGF-α and TGF-β1. The conditioned medium from fibroblasts enhanced in vitro invasion of IF cells, an event abrogated by anti-HGF antibody, but not by antibodies against TGF-α and TGF-β1. Importantly, IF cells secreted a factor inducing HGF production in fibroblasts and the factor was identified as interleukin-1, which means that a mutual interaction exists between tumour cells and fibroblasts, as mediated by the HGF/HGF-inducer loop. These results indicate that IF cells utilize TGF-α and TGF-β1 as autocrine-acting motility factors and HGF as a paracrine-acting motility factor, and that invasiveness of IF cells is particularly stimulated by HGF derived from stromal fibroblasts. Utilization of multiple cell motility/invasion factors that act in distinct pathways may confer highly invasive and metastatic potentials in IF oral squamous carcinoma cells. © 1999 Cancer Research Campaign

Keywords: cell motility factor, HGF, TGF-α, TGF-β, tumour invasion, tumour–stromal interaction

Full Text

The Full Text of this article is available as a PDF (509.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birchmeier C., Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 1998 Oct;8(10):404–410. doi: 10.1016/s0962-8924(98)01359-2. [DOI] [PubMed] [Google Scholar]
  2. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Camps J. L., Chang S. M., Hsu T. C., Freeman M. R., Hong S. J., Zhau H. E., von Eschenbach A. C., Chung L. W. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A. 1990 Jan;87(1):75–79. doi: 10.1073/pnas.87.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chicoine M. R., Silbergeld D. L. Mitogens as motogens. J Neurooncol. 1997 Dec;35(3):249–257. doi: 10.1023/a:1005808315821. [DOI] [PubMed] [Google Scholar]
  5. Date K., Matsumoto K., Kuba K., Shimura H., Tanaka M., Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene. 1998 Dec 10;17(23):3045–3054. doi: 10.1038/sj.onc.1202231. [DOI] [PubMed] [Google Scholar]
  6. Date K., Matsumoto K., Shimura H., Tanaka M., Nakamura T. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. 1997 Dec 22;420(1):1–6. doi: 10.1016/s0014-5793(97)01475-0. [DOI] [PubMed] [Google Scholar]
  7. Derynck R., Goeddel D. V., Ullrich A., Gutterman J. U., Williams R. D., Bringman T. S., Berger W. H. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 1987 Feb 1;47(3):707–712. [PubMed] [Google Scholar]
  8. Dunsmore S. E., Rubin J. S., Kovacs S. O., Chedid M., Parks W. C., Welgus H. G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem. 1996 Oct 4;271(40):24576–24582. doi: 10.1074/jbc.271.40.24576. [DOI] [PubMed] [Google Scholar]
  9. El-Obeid A., Bongcam-Rudloff E., Sörby M., Ostman A., Nistér M., Westermark B. Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. Cancer Res. 1997 Dec 15;57(24):5598–5604. [PubMed] [Google Scholar]
  10. Furlong R. A., Takehara T., Taylor W. G., Nakamura T., Rubin J. S. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci. 1991 Sep;100(Pt 1):173–177. doi: 10.1242/jcs.100.1.173. [DOI] [PubMed] [Google Scholar]
  11. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5844–5848. doi: 10.1073/pnas.86.15.5844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. doi: 10.1073/pnas.90.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Inoue T., Chung Y. S., Yashiro M., Nishimura S., Hasuma T., Otani S., Sowa M. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res. 1997 Feb;88(2):152–159. doi: 10.1111/j.1349-7006.1997.tb00360.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jeffers M., Rong S., Vande Woude G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996 Mar;16(3):1115–1125. doi: 10.1128/mcb.16.3.1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jiang W. G., Hallett M. B., Puntis M. C. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg. 1993 Nov;80(11):1368–1373. doi: 10.1002/bjs.1800801104. [DOI] [PubMed] [Google Scholar]
  16. Jiang W., Hiscox S., Matsumoto K., Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol. 1999 Feb;29(3):209–248. doi: 10.1016/s1040-8428(98)00019-5. [DOI] [PubMed] [Google Scholar]
  17. Konishi T., Takehara T., Tsuji T., Ohsato K., Matsumoto K., Nakamura T. Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem Biophys Res Commun. 1991 Oct 31;180(2):765–773. doi: 10.1016/s0006-291x(05)81131-3. [DOI] [PubMed] [Google Scholar]
  18. Lamszus K., Jin L., Fuchs A., Shi E., Chowdhury S., Yao Y., Polverini P. J., Laterra J., Goldberg I. D., Rosen E. M. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest. 1997 Mar;76(3):339–353. [PubMed] [Google Scholar]
  19. Levine M. D., Liotta L. A., Stracke M. L. Stimulation and regulation of tumor cell motility in invasion and metastasis. EXS. 1995;74:157–179. doi: 10.1007/978-3-0348-9070-0_8. [DOI] [PubMed] [Google Scholar]
  20. Matsumoto K., Date K., Shimura H., Nakamura T. Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res. 1996 Jul;87(7):702–710. doi: 10.1111/j.1349-7006.1996.tb00281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Matsumoto K., Horikoshi M., Rikimaru K., Enomoto S. A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med. 1989 Oct;18(9):498–501. doi: 10.1111/j.1600-0714.1989.tb01350.x. [DOI] [PubMed] [Google Scholar]
  22. Matsumoto K., Matsumoto K., Nakamura T., Kramer R. H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994 Dec 16;269(50):31807–31813. [PubMed] [Google Scholar]
  23. Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 1997 Oct 29;239(3):639–644. doi: 10.1006/bbrc.1997.7517. [DOI] [PubMed] [Google Scholar]
  24. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., Nakayama H., Hirono S., Sakiyama O., Takahashi K. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun. 1989 Sep 15;163(2):967–973. doi: 10.1016/0006-291x(89)92316-4. [DOI] [PubMed] [Google Scholar]
  25. Mooradian D. L., McCarthy J. B., Komanduri K. V., Furcht L. T. Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J Natl Cancer Inst. 1992 Apr 1;84(7):523–527. doi: 10.1093/jnci/84.7.523. [DOI] [PubMed] [Google Scholar]
  26. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 1997 Aug 1;57(15):3305–3313. [PubMed] [Google Scholar]
  27. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1450–1459. doi: 10.1016/0006-291x(84)91253-1. [DOI] [PubMed] [Google Scholar]
  28. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989 Nov 23;342(6248):440–443. doi: 10.1038/342440a0. [DOI] [PubMed] [Google Scholar]
  29. Naldini L., Weidner K. M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R. P., Hartmann G., Zarnegar R., Michalopoulos G. K. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 1991 Oct;10(10):2867–2878. doi: 10.1002/j.1460-2075.1991.tb07836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Okada F., Yamaguchi K., Ichihara A., Nakamura T. Purification and structural analysis of a latent form of transforming growth factor-beta from rat platelets. J Biochem. 1989 Aug;106(2):304–310. doi: 10.1093/oxfordjournals.jbchem.a122849. [DOI] [PubMed] [Google Scholar]
  31. Pepper M. S., Matsumoto K., Nakamura T., Orci L., Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem. 1992 Oct 5;267(28):20493–20496. [PubMed] [Google Scholar]
  32. Ridley A. J., Comoglio P. M., Hall A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol Cell Biol. 1995 Feb;15(2):1110–1122. doi: 10.1128/mcb.15.2.1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Russell W. E., McGowan J. A., Bucher N. L. Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol. 1984 May;119(2):183–192. doi: 10.1002/jcp.1041190207. [DOI] [PubMed] [Google Scholar]
  34. Shibamoto S., Hayakawa M., Takeuchi K., Hori T., Oku N., Miyazawa K., Kitamura N., Takeichi M., Ito F. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun. 1994 Jan;1(4):295–305. doi: 10.3109/15419069409097261. [DOI] [PubMed] [Google Scholar]
  35. Silletti S., Raz A. Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. Curr Top Microbiol Immunol. 1996;213(Pt 2):137–169. doi: 10.1007/978-3-642-61109-4_7. [DOI] [PubMed] [Google Scholar]
  36. Sporn M. B., Roberts A. B. Autocrine growth factors and cancer. 1985 Feb 28-Mar 6Nature. 313(6005):745–747. doi: 10.1038/313745a0. [DOI] [PubMed] [Google Scholar]
  37. Sporn M. B., Roberts A. B., Wakefield L. M., de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987 Sep;105(3):1039–1045. doi: 10.1083/jcb.105.3.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stoker M., Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta. 1991 Apr 16;1072(1):81–102. doi: 10.1016/0304-419x(91)90008-9. [DOI] [PubMed] [Google Scholar]
  39. Stoker M., Perryman M. An epithelial scatter factor released by embryo fibroblasts. J Cell Sci. 1985 Aug;77:209–223. doi: 10.1242/jcs.77.1.209. [DOI] [PubMed] [Google Scholar]
  40. Takaishi K., Sasaki T., Kato M., Yamochi W., Kuroda S., Nakamura T., Takeichi M., Takai Y. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene. 1994 Jan;9(1):273–279. [PubMed] [Google Scholar]
  41. Ueda M., Fujii H., Yoshizawa K., Abe F., Ueki M. Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro. Jpn J Cancer Res. 1996 May;87(5):524–533. doi: 10.1111/j.1349-7006.1996.tb00255.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ueda M., Ueki M., Terai Y., Morimoto A., Fujii H., Yoshizawa K., Yanagihara T. Stimulatory effects of EGF and TGF-alpha on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in uterine cervical-carcinoma SKG-IIIb cells. Int J Cancer. 1997 Sep 17;72(6):1027–1033. doi: 10.1002/(sici)1097-0215(19970917)72:6<1027::aid-ijc18>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  43. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  44. Watabe M., Matsumoto K., Nakamura T., Takeichi M. Effect of hepatocyte growth factor on cadherin-mediated cell-cell adhesion. Cell Struct Funct. 1993 Apr;18(2):117–124. doi: 10.1247/csf.18.117. [DOI] [PubMed] [Google Scholar]
  45. Wehrle-Haller B., Weston J. A. Receptor tyrosine kinase-dependent neural crest migration in response to differentially localized growth factors. Bioessays. 1997 Apr;19(4):337–345. doi: 10.1002/bies.950190411. [DOI] [PubMed] [Google Scholar]
  46. Weidner K. M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7001–7005. doi: 10.1073/pnas.88.16.7001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. doi: 10.1083/jcb.111.5.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Welch D. R., Fabra A., Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7678–7682. doi: 10.1073/pnas.87.19.7678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wernert N. The multiple roles of tumour stroma. Virchows Arch. 1997 Jun;430(6):433–443. doi: 10.1007/s004280050053. [DOI] [PubMed] [Google Scholar]
  50. Wright J. A., Huang A. Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF. Histol Histopathol. 1996 Apr;11(2):521–536. [PubMed] [Google Scholar]
  51. Wright J. A., Turley E. A., Greenberg A. H. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog. 1993;4(5):473–492. [PubMed] [Google Scholar]
  52. Zarnegar R., Michalopoulos G. K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995 Jun;129(5):1177–1180. doi: 10.1083/jcb.129.5.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. van den Hooff A. Stromal involvement in malignant growth. Adv Cancer Res. 1988;50:159–196. doi: 10.1016/s0065-230x(08)60437-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES